Epoetin zeta - Retacrit | Search results | NICE

Showing 1 result for epoetin zeta - retacrit

Sort by

Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy (TA323)
Evidence-based recommendations on erythropoiesis-stimulating agents (epoetin alfa [Eprex], epoetin beta [NeoRecormon], epoetin theta, epoeitin zeta [Retacrit] and darbepoetin alfa [Aranesp]) for treating anaemia in adults with cancer having chemotherapy.
Result type
Technology appraisal guidance
Published
26 November 2014
View recommendations for TA323
Show all sections
Sections for TA323